iRay Group (SHA:688301)
111.18
+4.58 (4.30%)
Apr 16, 2026, 3:00 PM CST
iRay Group Market Cap
iRay Group has a market cap or net worth of 23.5 billion as of April 16, 2026. Its market cap has increased by 44.61% in one year.
Market Cap
23.50B
Enterprise Value
24.61B
Revenue
2.25B
Ranking
n/a
PE Ratio
35.98
Stock Price
111.18
Market Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 23.50B, an increase of 102.31%. That is a compound annual growth rate of 13.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 22.53B | 5.50% |
| Dec 31, 2025 | 21.35B | 56.38% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gan & Lee Pharmaceuticals. | 38.27B |
| Intco Medical Technology | 35.64B |
| Imeik Technology Development | 35.10B |
| Andon Health | 32.67B |
| Zhende Medical | 22.43B |
| Winner Medical | 19.15B |
| Shenyang Xingqi Pharmaceutical | 16.86B |
| Micro-Tech (Nanjing) Co.,Ltd | 14.06B |